Note 12 - Subsequent Events	9 Months Ended
Mar. 31, 2012
Schedule of Subsequent Events [Table Text Block]	12. SUBSEQUENT EVENTS The Company has performed its subsequent events review through the filing of these financial statements. On April 18, 2012, the Company acquired the assets of Cyto Management System (“CMS”) from Cobbler ICT Services BV for $2,200,000 cash. The CMS software, which is currently deployed in Holland and Belgium, provides healthcare organizations a chemotherapy management solution to track patients, manage highly individualized medication-based treatment plans and help control costs and report outcomes associated with cancer therapies. The software utilizes a multilingual language platform that facilitates configuration for new international markets. The CMS acquisition provides Mediware the opportunity to enhance its systems and services offerings in JAC's current markets and to enter new markets. The purchase price allocation has not yet been determined, but is not expected to be material to Mediware’s financial statements. The acquired business will be included in the results of the Company from the effective date of the acquisition, April 18, 2012.

Note 12 - Subsequent Events

9 Months Ended

Mar. 31, 2012

Schedule of Subsequent Events [Table Text Block]

12. SUBSEQUENT EVENTS

The Company has performed its subsequent events review through the filing of these financial statements.

On April 18, 2012, the Company acquired the assets of Cyto Management System (“CMS”) from Cobbler ICT Services BV for $2,200,000 cash. The CMS software, which is currently deployed in Holland and Belgium, provides healthcare organizations a chemotherapy management solution to track patients, manage highly individualized medication-based treatment plans and help control costs and report outcomes associated with cancer therapies.

The software utilizes a multilingual language platform that facilitates configuration for new international markets. The CMS acquisition provides Mediware the opportunity to enhance its systems and services offerings in JAC's current markets and to enter new markets.

The purchase price allocation has not yet been determined, but is not expected to be material to Mediware’s financial statements. The acquired business will be included in the results of the Company from the effective date of the acquisition, April 18, 2012.

- Definition

Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.

+ References+ Details